8:00 am
Registration/Check-in
8:50 am
Welcoming Remarks
Gerry Boss, MD, University of California San Diego
SESSION I
Jing Yang, PhD - University of California San Diego (Moderator)
9:00 am
Modelling Tumor-Stroma Interactions
Erik Sahai, PhD - Francis Crick Institute, London, UK
9:30 am
Discussion
9:40 am
Tumor Stroma as a Driver of Treatment Resistance
Taru Muranen, PhD - Beth Israel Deaconess Medical Center at Harvard University
10:10 am
Discussion
10:20 am
Matrix and Macrophages: Critical Roles in Leptomeningeal Metastasis
Dorothy Sipkins, MD, PhD - Duke University School of Medicine
10:50 am
Discussion
11:00 am
Break
SESSION II
Christian Metallo, PhD - Salk Institute (Moderator)
11:15 am
3D Analyses of Human Pancreatic Neoplasms
Laura Wood, MD, PhD - Johns Hopkins University
11:45 am
Discussion
11:55 am
Modeling the Continuum of Pancreatic Pathogenesis
Dannielle Engle, PhD - Salk Institute
12:25 pm
Discussion
12:35 pm
Lunch on own (please see registration for a list of suggestions)
2:00 pm
Dietary Control of Stem Cells in Physiology and Disease
Ömer H. Yilmaz, MD, PhD - Koch Institute for Integrative Cancer Research at MIT
2:30 pm
Discussion
SESSION III
Brooke Emerling, PhD - Sanford Burnham Prebys Medical Discovery Institute (Moderator)
2:40 pm
Identifying Metabolic Vulnerabilities of Primary Tumours and Metastasis
Mariia Yuneva, PhD - Calico Life Sciences
3:10 pm
Discussion
3:20 pm
Break
3:35 pm
Charting Therapeutic Vulnerabilities in Rare Tumors with Patient-Derived Organoid Models
Alice Soragni, PhD - UCLA Health
4:05 pm
Discussion
4:15 pm
Organoid Models of Tissue and Tumor-Resident Immunity
Calvin Kuo, MD, PhD - Stanford University School of Medicine
4:45 pm
Discussion
4:55 pm
Closing Remarks
Jing Yang, PhD - University of California San Diego
5:00 pm
Final Adjournment